US Stock MarketDetailed Quotes
APLS Apellis Pharmaceuticals
- 47.510
- -0.520-1.08%
Close Apr 18 16:00 ET
- 47.510
- 0.0000.00%
Post 17:33 ET
5.73BMarket Cap-10676P/E (TTM)
48.830High46.400Low1.95MVolume47.910Open48.030Pre Close92.17MTurnover2.40%Turnover RatioLossP/E (Static)120.58MShares94.75052wk High29.45P/B3.85BFloat Cap19.83052wk Low--Dividend TTM81.04MShs Float94.750Historical High--Div YieldTTM5.06%Amplitude11.450Historical Low47.354Avg Price1Lot Size
About Apellis Pharmaceuticals Company
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.
Company Profile
SymbolAPLS
Company NameApellis Pharmaceuticals
Listing DateNov 9, 2017
Issue Price14.00
Founded2009
CEODr. Cedric Francois, M.D.
MarketNASDAQ
Employees706
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address100 5th Avenue
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451-8703
Phone1-617-977-5700
Websitehttp://www.apellis.com
Company Executives
- Name
- Position
- Salary
- Dr. Cedric Francois, M.D.
- Director, Chief Executive Officer and President
- 9.20M
- Pascal Deschatelets, PhD
- Chief Scientific Officer
- 3.08M
- James George Chopas
- Vice President, Corporate Controller and Chief Accounting Officer
- --
- Nur Nicholson
- Chief Technical Operations Officer
- --
- Dr. Lukas Scheibler, PhD
- Chief Innovation Officer
- --
- Timothy E. Sullivan
- Chief Financial Officer and Treasurer
- 3.55M
- Dr. Jeffrey Eisele, PhD
- Chief Development Officer
- --
- Mark Jeffrey DeLong
- Chief Business and Strategy Officer
- --
- Dr. Caroline Baumal, M.D.
- Chief Medical Officer
- --
- Karen Lewis
- Chief People Officer
- --
- Adam J. Townsend
- Chief Operating Officer
- 3.10M
- Dr. Gerald L. Chan, Sc.D.
- Chairman of the Board
- 495.92K
- Alec Machiels
- Independent Director
- 479.67K
- Paul Fonteyne
- Independent Director
- 469.67K
- Stephanie Monaghan O’Brien
- Independent Director
- 472.17K
- A. Sinclair Dunlop
- Independent Director
- 467.17K
- David Watson
- General Counsel
- 3.07M
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
